Kevin Tang is an investor and executive in the life sciences sector. He founded Tang Capital Management and has held leadership roles at several pharmaceutical and biotechnology companies.
At firms with a similar stage, sector and check size.




One email when Kevin's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckKevin Tang is an investor and executive in the life sciences sector. He founded Tang Capital Management and has held leadership roles at several pharmaceutical and biotechnology companies.
Tang Capital Management has not reported a check size. It invests at series a, series b.
A warm intro from a founder Tang Capital Management backed works best.
Director at Ardea Biosciences, Inc.; Director at Heron Therapeutics, Inc.; Director at Penwest Pharmaceuticals Co.; Chairman at Heron Therapeutics, Inc.; Chairman and Chief Executive Officer at Odonate Therapeutics, Inc.; Chairman at La Jolla Pharmaceutical Company; Chair of the Board at Aurinia Pharmaceuticals Inc.; Chief Executive Officer at Aurinia Pharmaceuticals Inc..
Last updated 2026-10-15. Is this you? Ask for a correction.